Last news
DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway

DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway

HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as...

BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials

BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials

BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody –drug conjugate (ADC) to enter clinical development. BioDlink enabled IND...

Acer Announces January 2026 Revenues at NT$21.08 Billion, Up 39.8% Year-on-year, Highest January Revenue Post Pandemic

Acer Announces January 2026 Revenues at NT$21.08 Billion, Up 39.8% Year-on-year, Highest January Revenue Post Pandemic

TAIPEI, Feb. 9, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for January 2026 at NT$21.08 billion, up 39.8% year-on-year (YoY), the highest January revenue post pandemic. Highlights in January include: Revenues...

DAR GLOBAL DEBUTS NICKELODEON HOTELS & RESORTS OMAN IN AIDA, THE ICONIC BRAND OF FAMILY ENTERTAINMENT

DAR GLOBAL DEBUTS NICKELODEON HOTELS & RESORTS OMAN IN AIDA, THE ICONIC BRAND OF FAMILY ENTERTAINMENT

MUSCAT, Sultanate of Oman, Feb. 9, 2026 /PRNewswire/ -- Dar Global, the London-listed luxury real estate developer, has unveiled Nickelodeon Hotels & Resorts Oman at its landmark AIDA development. The project marks a significant addition to...

AV-Comparatives Publishes Security Survey 2026: Global Trends in Cybersecurity Adoption and Threat Perception

AV-Comparatives Publishes Security Survey 2026: Global Trends in Cybersecurity Adoption and Threat Perception

INNSBRUCK, Austria, Feb. 9, 2026 /PRNewswire/ -- AV-Comparatives, the leading independent authority on cybersecurity testing and research, today announced the release of the Security Survey 2026, a comprehensive global study capturing current user...

'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai

'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai

MUMBAI, India, Feb. 9, 2026 /PRNewswire/ -- Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS:...

Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant - Successful Launch of Advanced Automated Workstation at BASF

Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant - Successful Launch of Advanced Automated Workstation at BASF

SHANGHAI, Feb. 9, 2026 /PRNewswire/ -- Chemistry serves as the foundational pillar of material innovation and transformation. It supports and shapes almost every aspect of modern industries. Recently, XtalPi Inc. (2228.HK), a global leader in AI-...

PMET Announces Up To Aggregate C$130 Million Financings to Advance Shaakichiuwaanaan - Through a Flow-Through Private Placement and a Public Offering of Common Shares

PMET Announces Up To Aggregate C$130 Million Financings to Advance Shaakichiuwaanaan - Through a Flow-Through Private Placement and a Public Offering of Common Shares

/NOT FOR RELEASE TO U.S. NEWS WIRE SERVICES OR DISTRIBUTION IN THE UNITED STATES/ Proceeds to support updated CV5 Feasibility Study, advancement of critical minerals co-products and unlocking value through exploration success The prospectus...

1 ... 17 18 19 20 21 22 23 24 25 ... 3729
menu
menu